Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16,787 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mucosal Immune System Dysregulation in the Pathogenesis of IgA Nephropathy.
Kano T, Suzuki H, Makita Y, Nihei Y, Fukao Y, Nakayama M, Lee M, Kato R, Aoki R, Yamada K, Muto M, Suzuki Y. Kano T, et al. Among authors: suzuki h, suzuki y. Biomedicines. 2022 Nov 24;10(12):3027. doi: 10.3390/biomedicines10123027. Biomedicines. 2022. PMID: 36551783 Free PMC article. Review.
Galectin-3 contributes to pathogenesis of IgA nephropathy.
Chou YL, Chen HL, Hsu BG, Yang CY, Chen CH, Lee YC, Tsai IL, Sung CC, Wu CC, Yang SR, Suzuki Y, Yates E, Hua KF, Yu LG, Liu FT, Chen A, Ka SM. Chou YL, et al. Among authors: suzuki y. Kidney Int. 2024 Oct;106(4):658-670. doi: 10.1016/j.kint.2024.06.023. Epub 2024 Jul 29. Kidney Int. 2024. PMID: 39084257
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy.
Mathur M, Barratt J, Chacko B, Chan TM, Kooienga L, Oh KH, Sahay M, Suzuki Y, Wong MG, Yarbrough J, Xia J, Pereira BJG; ENVISION Trial Investigators Group. Mathur M, et al. Among authors: suzuki y. N Engl J Med. 2024 Jan 4;390(1):20-31. doi: 10.1056/NEJMoa2305635. Epub 2023 Nov 2. N Engl J Med. 2024. PMID: 37916620 Free PMC article. Clinical Trial.
Guidelines for clinical evaluation of chronic kidney disease in early stages : AMED research on regulatory science of pharmaceuticals and medical devices.
Sugawara Y, Kanda E, Hamano T, Itano S, Okada H, Tomori K, Watanabe Y, Asakura W, Isaka Y, Iseki K, Usui T, Suzuki Y, Tanaka M, Nishimura R, Fukami K, Matsushita K, Wada J, Watada H, Ueki K, Kashihara N, Nangaku M; Research Working Group for Establishing Guidelines for Clinical Evaluation of Chronic Kidney Disease. Sugawara Y, et al. Among authors: suzuki y. Clin Exp Nephrol. 2024 Sep;28(9):847-865. doi: 10.1007/s10157-024-02514-6. Epub 2024 Jul 6. Clin Exp Nephrol. 2024. PMID: 38970650 Free PMC article.
16,787 results
You have reached the last available page of results. Please see the User Guide for more information.